[SIEN] Sientra, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Industrial Specialties

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 8.6 Change: 0.27 (3.24%)
Ext. hours: Change: 0 (0%)

chart SIEN

Refresh chart

Strongest Trends Summary For SIEN

SIEN is in the medium-term up 25% in 4 weeks and down -42% in 4 months. In the long-term up 126% in 4 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons and patients in the United States. The company offers a portfolio of silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; and breast tissue expanders. It also provides body contouring and other implants, including gluteal, pectoral, calf, facial, and nasal implants, as well as nasal stents; silicone elastomer oval carving blocks to treat deformity caused by trauma, congenital and other deformities, or cancer therapy; scar management specialty products under the Medgel brand to treat various types of scars; breast sizers to identify the style and size of implants; and non-breast tissue expanders for expanding tissue and skin surface area for burn care and other reconstructive use. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barb

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 16.53% Sales Growth - Q/Q2.62% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-5.9% ROE-8.65% ROI-7.08%
Current Ratio5.34 Quick Ratio4.47 Long Term Debt/Equity0.2 Debt Ratio0.24
Gross Margin73.65% Operating Margin-16.57% Net Profit Margin-22.81% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-30 K Cash From Investing Activities-140 K Cash From Operating Activities-2.97 M Gross Profit9.2 M
Net Profit-3.38 M Operating Profit-2.63 M Total Assets136.1 M Total Current Assets120.69 M
Total Current Liabilities22.61 M Total Debt25.55 M Total Liabilities43.27 M Total Revenue12.43 M
Technical Data
High 52 week25.57 Low 52 week9.06 Last close14.83 Last change2.7%
RSI65.18 Average true range1.02 Beta1.05 Volume75.14 K
Simple moving average 20 days7.82% Simple moving average 50 days-10.6% Simple moving average 200 days-19.63%
Performance Data
Performance Week8.72% Performance Month-13.93% Performance Quart-32% Performance Half-25.36%
Performance Year9.45% Performance Year-to-date16.68% Volatility daily4.59% Volatility weekly10.27%
Volatility monthly21.05% Volatility yearly72.91% Relative Volume72.8% Average Volume392.32 K
New High New Low

News

2019-01-07 08:00:00 | Sientra Announces Preliminary Unaudited Fourth Quarter 2018 Net Sales and Appointment of Aesthetic Industry Veteran to Board of Directors

2018-12-23 02:48:17 | Is Sientra Inc SIEN A Good Stock To Buy?

2018-12-12 11:22:41 | How Much Did Sientra, Inc.’s NASDAQ:SIEN CEO Pocket Last Year?

2018-12-10 08:01:00 | Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635c4

2018-11-27 08:45:00 | New Research Coverage Highlights Phibro Animal Health, RadNet, Amphastar Pharmaceuticals, FibroGen, Sientra, and Flexion Therapeutics — Consolidated Revenues, Company Growth, and Expectations for 2018

2018-11-12 08:41:01 | Implied Volatility Surging for Sientra SIEN Stock Options

2018-11-07 01:30:11 | Edited Transcript of SIEN earnings conference call or presentation 6-Nov-18 9:30pm GMT

2018-11-06 18:15:11 | Sientra SIEN Reports Q3 Loss, Tops Revenue Estimates

2018-11-06 17:11:43 | Sientra: 3Q Earnings Snapshot

2018-11-06 16:01:00 | Sientra Reports Third Quarter 2018 Financial Results

2018-10-31 16:01:00 | Sientra to Participate in Upcoming Investor Conferences

2018-10-23 16:05:00 | Sientra® to Release Third Quarter 2018 Financial Results on November 6, 2018

2018-10-23 05:00:00 | Sientra Announces FULL CIRCLE Grant Recipients

2018-10-16 07:55:00 | Investor Expectations to Drive Momentum within Cincinnati Bell, Hooker Furniture, AgroFresh Solutions, Forward Industries, Abeona Therapeutics, and Sientra — Discovering Underlying Factors of Influence

2018-10-12 08:56:12 | Are Options Traders Betting on a Big Move in Sientra SIEN Stock?

2018-09-19 15:36:33 | SEC sues U.S. breast-implant company's ex-CEO after stock dive

2018-09-19 14:35:44 | SEC sues ex-CEO of California breast implant company after stock nosedived

2018-08-16 07:35:00 | Analysis: Positioning to Benefit within Amtech, NL Industries, Dova Pharmaceuticals, Sientra, Dorian LPG, and Assembly Biosciences — Research Highlights Growth, Revenue, and Consolidated Results

2018-08-15 08:00:00 | Sientra FULL CIRCLE™ Grant Applications Open to U.S. Breast Cancer Organizations

2018-08-10 16:01:00 | Sientra Reports Inducement Grant Under Nasdaq Listing Rule 5635c4

2018-08-07 17:38:43 | Sientra: 2Q Earnings Snapshot

2018-08-07 16:01:00 | Sientra Reports Second Quarter 2018 Financial Results

2018-08-07 14:30:00 | Sientra, Inc. to Host Earnings Call

2018-07-31 08:00:00 | Sientra to Launch State-of-the-Art Innovation Facility

2018-07-25 08:00:00 | Sientra to Present at the Canaccord 38th Annual Growth Stock Conference

2018-07-24 16:01:00 | Sientra® to Release Second Quarter 2018 Financial Results on August 7, 2018

2018-07-02 08:46:12 | Implied Volatility Surging for Sientra SIEN Stock Options

2018-06-27 07:45:00 | Complimentary Technical Snapshots on Merit Medical Systems and Three More Medical Supplies Stocks

2018-06-04 16:01:00 | Sientra to Present at the William Blair 38th Annual Growth Stock Conference

2018-05-29 08:30:00 | Consolidated Research: 2018 Summary Expectations for B. Riley Financial, Woodward, Sientra, NL Industries, Aquantia, and Multi-Color — Fundamental Analysis, Key Performance Indications

2018-05-22 07:10:00 | Free Daily Technical Summary Reports on Valeritas and Three Other Medical Supplies Stocks

2018-05-10 03:46:03 | Edited Transcript of SIEN earnings conference call or presentation 9-May-18 8:30pm GMT

2018-05-09 17:18:20 | Sientra: 1Q Earnings Snapshot

2018-05-09 16:01:00 | Sientra Reports First Quarter 2018 Financial Results

2018-05-07 16:01:00 | Sientra, Inc. Announces Closing of $115 Million Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option

2018-05-04 16:01:00 | Sientra® to Release First Quarter 2018 Financial Results on Wednesday, May 9, 2018

2018-05-03 06:00:00 | Sientra Announces Pricing of Upsized Public Offering of Common Stock

2018-04-30 07:01:00 | Sientra Commences Public Offering of Common Stock

2018-04-25 08:30:00 | Sientra to Showcase OPUS™ Breast Products and miraDry fresh™ Procedure at American Society of Aesthetic Plastic Surgeons Meeting

2018-04-18 16:01:00 | Sientra Receives FDA Approval of PMA Supplement

2018-04-04 08:10:00 | Factors of Influence in 2018, Key Indicators and Opportunity within Sientra, Primo Water, Andeavor Logistics LP, RE/MAX, Seaboard, and Kaiser Aluminum -- New Research Emphasizes Economic Growth

2018-03-14 19:21:29 | Edited Transcript of SIEN earnings conference call or presentation 13-Mar-18 8:30pm GMT

2018-03-13 16:19:28 | Sientra reports 4Q loss

2018-03-13 16:01:00 | Sientra Reports Fourth Quarter and Full Year 2017 Financial Results

2018-03-13 12:00:00 | Sientra, Inc. to Host Earnings Call

2018-03-02 16:01:00 | Sientra® to Release Fourth Quarter and Full Year 2017 Financial Results on Tuesday, March 13, 2017

2018-02-16 08:30:00 | Sientra Launches New miraDry fresh™ Protocol for the miraDry® System at American Academy of Dermatology Annual Meeting

2018-01-30 16:01:00 | Sientra® Provides Update on FDA Review of U.S. Manufacturing Facility

2018-01-25 16:01:00 | Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635c4

2018-01-08 08:00:00 | Sientra Announces Preliminary Unaudited Fourth Quarter 2017 Revenue